Literature DB >> 25344853

[Experience with fecal transplantation in the treatment of Clostridium difficile infection].

Szabolcs Vigvári1, Zsuzsanna Nemes1, Aron Vincze2, Jenő Solt2, Dávid Sipos1, Zsófia Feiszt1, Agnes Kappéter1, Beáta Kovács1, Zoltán Péterfi1.   

Abstract

INTRODUCTION: During the past years a dramatic change has been observed in the epidemiology of Clostridium difficile infections. AIM: The aim of the authors was to investigate the possibility of the fecal microbiota transplantation and study differences, if any, in the success rate of the two different upper gastrointestinal tract method.
METHOD: 100 ml of fecal microbiota solution was instilled via a nasoduodenal tube in 15 cases and a nasogastric tube in 15 cases. The authors defined the primary cure rate as the percentage of cases in which the symptoms disappeared without recurrence within 6 weeks after the first fecal microbiota transplantation, while secondary cure rate was calculated as the percentage of cases in which the symptoms resolved after the second fecal microbiota transplantation.
RESULTS: It was found that fecal microbiota transplantation applied via the nasoduodenal tube resulted in a 100% primary cure rate. With the use of the nasogastric tube, the primary and secondary cure rate were 80% and 93.3%, respectively. Fecal microbiota transplantation via the upper gastrointestinal tract was found to have an overall primary cure rate of 90.0% and a secondary cure rate of 96.7%.
CONCLUSIONS: Fecal microbiota transplantation proved to be very effective, particularly in recurrent infections and cases where conventional treatment failed.

Entities:  

Keywords:  Clostridium difficile infection; Clostridium difficile-infekció; fecal microbiota transplantation; nasoduodenal tube; nasoduodenalis szonda; nasogastric tube; nasogastricus szonda; széklettranszplantáció

Mesh:

Year:  2014        PMID: 25344853     DOI: 10.1556/OH.2014.30020

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  3 in total

1.  GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015.

Authors: 
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

2.  Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations.

Authors:  Johan S Bakken
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

3.  How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.

Authors:  Adorján Varga; Béla Kocsis; Dávid Sipos; Péter Kása; Szabolcs Vigvári; Szilárd Pál; Fanni Dembrovszky; Kornélia Farkas; Zoltán Péterfi
Journal:  Front Cell Infect Microbiol       Date:  2021-06-04       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.